Acute demyelinating disease after interferon beta-1a treatment for multiple sclerosis

Neurology. 2000 Nov 14;55(9):1416-7. doi: 10.1212/wnl.55.9.1416.
No abstract available

MeSH terms

  • Adult
  • Demyelinating Diseases / etiology*
  • Humans
  • Interferon beta-1a
  • Interferon-beta / adverse effects*
  • Interferon-beta / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Interferon-beta
  • Interferon beta-1a